|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4375 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| A61K 31/00 | |||
| A61K 31/506 |
| (11) | Number of the document | 2968286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14764032.0 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029661 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/145025 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361792812 P | 2013-03-15 | US |
| (72) |
KAUFMAN, Michael D., US
FLYNN, Daniel L, US
AHN, Yu Mi, US
VOGETI, Lakshminarayana, US
CALDWELL, Timothy Malcolm, US
|
| (73) |
Deciphera Pharmaceuticals, LLC,
643 Massachusetts, Suite 200, Lawrence, Kansas 66044,
US
|
| (54) | 2-AMINOPYRIMIDIN-6-ONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES |
| 2-AMINOPYRIMIDIN-6-ONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES |